CanSino Biologics Inc. (6185) - Financials, balance sheet (quarterly)

35.35000 HKD

2.65

8.10%

Last update May 21, 3:59 PM HKT

Main market

Day range

35.35000

32.35000

37.95000

Previous close

32.70000

Open

32.35000

Access this stock data via API

CanSino Biologics Inc.

35.35

2.65

8.10%

Financials

Balance sheet

Fiscal date	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total assets	8.1B	8.6B	9.3B	9.6B
Current assets	4.5B	5.0B	5.2B	5.5B
Cash	—	—	2.0B	—
Cash equivalents	—	—	899K	—
Cash and cash equivalents	1.7B	2.6B	2.0B	3.2B
Other short term investments	1.8B	1.4B	2.1B	1.1B
Accounts receivable	578.1M	595.1M	636.9M	653.0M
Other receivables	59.4M	10.3M	59.9M	7.7M
Inventory	359.6M	355.4M	350.7M	417.4M
Prepaid assets	—	45.1M	—	79.2M
Restricted cash	12.0M	—	11.2M	—
Assets held for sale	—	—	—	—
Hedging assets	—	811.3K	—	4.4K
Other current assets	—	2.2M	—	27.9M
Non current assets	3.6B	3.5B	4.1B	4.1B
Properties	2.6B	1.4B	1.3B	1.9B
Land and improvements	—	—	—	—
Machinery furniture equipment	—	—	80.3M	—
Construction in progress	—	943.0M	1.3B	977.0M
Leases	—	—	—	—
Accumulated depreciation	—	—	-865.2M	—
Goodwill	150.1M	215.4M	205.6M	246.7M
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	—	215.4M	205.6M	246.7M
Investments and advances	—	—	—	—
Other non current assets	—	561.0M	—	558.9M
Total liabilities	3.1B	3.5B	4.0B	3.8B
Current liabilities	1.9B	2.1B	2.6B	2.5B
Accounts payable	77.8M	72.4M	104.0M	130.2M
Accrued expenses	—	—	—	—
Short term debt	1.2B	955.0M	1.5B	852.4M
Deferred revenue	—	—	—	—
Tax payable	132K	37.4M	—	4.9M
Pensions	—	132.4M	—	97.3M
Other current liabilities	—	409.8M	—	758.6M
Non current liabilities	1.2B	1.4B	1.4B	1.3B
Long term provisions	—	—	—	—
Long term debt	1.0B	1.2B	1.2B	1.1B
Provision for risks and charges	—	—	8.5M	—
Deferred liabilities	—	—	—	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	—	8.5M	—	8.5M
Shareholders equity
Common stock	6.8B	247.4M	247.5M	247.4M
Retained earnings	-1.8B	-1.7B	-1.6B	-1.1B
Other shareholders equity	—	—	—	—
Total shareholders equity	5.1B	5.1B	5.3B	5.8B
Additional paid in capital	—	—	6.6B	—
Treasury stock	98.8M	106.2M	106.2M	106.2M
Minority interest	0	0	12.8M	27.6M